MTOR and tuberous sclerosis: Novel therapeutic options for TSC-associated epilepsy provide promising alternatives for children and adults with TSC and include disease-modifying treatment with mTOR inhibitors (sirolimus, everolimus) [10, 11] and cannabidiol, which has recently been approved as an antiseizure medication (ASM) in TSC-associated refractory epilepsy [12].